Adjunctive Nonconvulsive Electrotherapy for Patients with Depression: a Systematic Review
- 22 June 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Psychiatric Quarterly
- Vol. 92 (4), 1645-1656
- https://doi.org/10.1007/s11126-021-09936-5
Abstract
The efficacy and safety of adjunctive nonconvulsive electrotherapy (NET) for patients with depression are undetermined. This systematic review was conducted to examine the efficacy and safety of adjunctive NET for patients with depression. Chinese (WanFang and Chinese Journal Net) and English (PubMed, EMBASE, PsycINFO and the Cochrane Library) databases were systematically searched from their inception until Jan 27, 2021 by three independent investigators. One randomized controlled trial (RCT) with 3 treatment arms (n = 108) and two observational studies (single-group, before-after design, n = 31) were included. In the RCT, the antidepressant efficacy of NET on depression was similar to that of electroconvulsive therapy (ECT) (P > 0.05) but with significantly fewer neurocognitive impairments as measured by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) (P < 0.05). In two observational studies, the 17-item Hamilton Depression Rating Scale (HAMD-17) scores decreased significantly from baseline to post-NET (all Ps < 0.05), without adverse neurocognitive effects. In the RCT, adverse drug reactions (ADRs) were not separately reported among the 3 treatment arms but a similar rate of discontinuation was reported. The currently available limited evidence from 3 studies suggests that NET as an adjunctive treatment may be a safe, well-tolerated, effective therapy for depression without serious neurocognitive impairments.Keywords
This publication has 30 references indexed in Scilit:
- Efficacy, safety and tolerability of formula-based unilateral vs bilateral electroconvulsive therapy in the treatment of major depression: A randomized open label controlled trialJournal of Psychiatric Research, 2020
- Precision non-implantable neuromodulation therapies: a perspective for the depressed brainRevista Brasileira de Psiquiatria, 2020
- Treating major depression and comorbid disorders with transcranial magnetic stimulationJournal of Affective Disorders, 2020
- Management of Treatment-Resistant Depression: Challenges and StrategiesNeuropsychiatric Disease and Treatment, 2020
- Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of DepressionBritish Journal of Psychology, 2018
- Effect of Probiotics on Depression: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsNutrients, 2016
- Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transitionThe Lancet, 2015
- Association between antidepressant side effects and functional impairment in patients with major depressive disordersPsychiatry Research, 2013
- Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical PracticeAmerican Journal of Psychiatry, 2006
- Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysisThe Lancet, 2003